The newly launched AltoStar® Influenza Screen & Type RT-PCR Kit 1.5 enables the fast and reliable detection and differentiation of the currently known subtypes and strains of globally spread influenza viruses.
AltoStar® SARS-CoV-2 RT-PCR Kit 1.0 RUO (#AS0821503) is a reagent system, based on real-time PCR technology, for the qualitative detection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) specific RNA.
The RUO Instructions for Use are provided on our website.
AltoStar® SARS-CoV-2 RT-PCR Kit 1.0 RUO (#AS0821503) is a reagent system, based on real-time PCR technology, for the qualitative detection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) specific RNA.
The RUO Instructions for Use are provided on our website.
UKE untersucht Häufigkeit und Schwere von COVID-19-Infektionen bei Kindern. Die Studie wird auch von altona Diagnostics gefördert.
altona Diagnostics Brasil LTDA, São Paulo, the brazilian subsidiary of altona Diagnostics GmbH, obtained the approval of the registration at ANVISA, the Brazilian Health Authority, for its real-time PCR kit to detect the RNA of SARS-CoV-2, causative agent of COVID-19.
altona Diagnostics successfully achieved CE certification for the RealStar® SARS-CoV-2 RT-PCR Kit 1.0
altona Diagnostics GmbH
Mörkenstr. 12
22767 Hamburg, Germany